Urinary proteome analysis in congenital bilateral hydronephrosis

References

• Yiee J, Wilcox D. Management of fetal hydronephrosis. Pediatr Nephrol 2008;23:347–53.
   PubMed Web of Science ®Google Scholar
• Scott JE, Renwick M. Urological anomalies in the Northern Region Fetal Abnormality Survey. Arch Dis Child 1993;68:22–6.
   PubMed Web of Science ®Google Scholar
• Ismaili K, Hall M, Donner C, Thomas D, Vermeylen D, Avni FE. Results of systematic screening for minor degrees of fetal renal pelvis dilatation in an unselected population. Am J Obstet Gynecol 2003;188:242–6.
   PubMedGoogle Scholar
• Helin I, Persson PH. Prenatal diagnosis of urinary tract abnormalities by ultrasound. Pediatrics 1986;78:879–83.
   PubMedGoogle Scholar
• Dhillon HK. Prenatally diagnosed hydronephrosis: the Great Ormond Street experience. Br J Urol 1998;81:39–44.
   PubMedGoogle Scholar
• Cortes D, Jorgensen TM, Rittig S, Thaarup J, Hansen A, Andersen KV, Prenatal diagnosed hydronephrosis and other urological anomalies. Ugeskr Laeger 2006;168:2544–50.
   PubMedGoogle Scholar
• Thorup J, Jokela R, Cortes D, Nielsen OH. The results of 15 years of consistent strategy in treating antenatally suspected pelvi-ureteric junction obstruction. BJU Int 2003;91:850–2.
   PubMed Web of Science ®Google Scholar
• Madsen MG, Norregaard R, Frokiaer J, Jorgensen TM. Urinary biomarkers in prenatally diagnosed unilateral hydronephrosis. J Pediatr Urol 2011;7:105–12.
   PubMed Web of Science ®Google Scholar
• Decramer S, Wittke S, Mischak H, Zurbig P, Walden M, Bouissou F, Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 2006;12:398–400.
   PubMed Web of Science ®Google Scholar
• Decramer S, Rbig ZU, Wittke S, Mischak H, Bascands JL, Schanstra JP. Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy. Contrib Nephrol 2008;160:127–41.
   PubMed Web of Science ®Google Scholar
• Drube J, Zurbig P, Schiffer E, Lau E, Ure B, Gluer S, Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol 2010;25:1673–8.
   PubMed Web of Science ®Google Scholar
• Mesrobian HG, Mitchell ME, See WA, Halligan BD, Carlson BE, Greene AS, Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach. J Urol 2010;184:709–14.
   PubMed Web of Science ®Google Scholar
• Palmfeldt J, Vang S, Stenbroen V, Pedersen CB, Christensen JH, Bross P, Mitochondrial proteomics on human fibroblasts for identification of metabolic imbalance and cellular stress. Proteome Sci 2009;7:20.
   PubMedGoogle Scholar
• Carvalho PC, Fischer JS, Chen EI, Yates JR III, Barbosa VC. PatternLab for proteomics: a tool for differential shotgun proteomics. BMC Bioinformatics 2008;9:316.
   PubMed Web of Science ®Google Scholar
• Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477–82.
   PubMed Web of Science ®Google Scholar
• Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H, Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 1997;8:1889–98.
   PubMed Web of Science ®Google Scholar
• Schrader J, Gallimore MJ, Eisenhauer T, Isemer FE, Schoel G, Warneke G, Parameters of the kallikrein-kinin, coagulation and fibrinolytic systems as early indicators of kidney transplant rejection. Nephron 1988;48:183–9.
   PubMedGoogle Scholar
• Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabetes Complications 1998;12:43–60.
   PubMed Web of Science ®Google Scholar
• Matheson A, Willcox MD, Flanagan J, Walsh BJ. Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 2010;26:150–71.
   PubMed Web of Science ®Google Scholar
• Safirstein R, Megyesi J, Saggi SJ, Price PM, Poon M, Rollins BJ, Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 1991;261:F1095–101.
   Google Scholar
• Lynn KL, Marshall RD. Excretion of Tamm–Horsfall glycoprotein in renal disease. Clin Nephrol 1984;22:253–7.
   PubMed Web of Science ®Google Scholar
• Johnstone LM, Jones CL, Walker RG, Powell HR. Tamm–Horsfall protein: are serum levels a marker for urinary tract obstruction? Pediatr Nephrol 1994;8:689–93.
   PubMed Web of Science ®Google Scholar
• Kaefer M, Peters CA, Retik AB, Benacerraf BB. Increased renal echogenicity: a sonographic sign for differentiating between obstructive and nonobstructive etiologies of in utero bladder distension. J Urol 1997;158:1026–9.
   PubMedGoogle Scholar
• Churchill BM, McLorie GA, Khoury AE, Merguerian PA, Houle AM. Emergency treatment and long-term follow-up of posterior urethral valves. Urol Clin North Am 1990;17:343–60.
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales L, Levin NW. Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients. Kidney Int 2003;63:315–22.
   PubMedGoogle Scholar
• Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1999;13:273–9.
   PubMed Web of Science ®Google Scholar